Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2016 May 11;8(6):1156–1166. doi: 10.1080/19420862.2016.1183083

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© Taylor & Francis Group, LLC

PMC Copyright notice

Figure 6. — Therapeutic efficacy of antibody 100F4 against H5N8 NE14 or H5N6 SC14 virus compared to oseltamivir treatment in mice. (A) The time course of body weight changes. (B) The survival rate of different antibody and oseltamivir treatment groups delivered at 24 hours after the H5N8 NE14 infection. (C) The time course of body weight changes. (D) The survival rate of different antibody and oseltamivir treatment groups delivered at 72 hours after the H5N8 NE14 virus infection. Survival rate was calculated as percent survival within each experimental group (n = 5 mice per group). (E) The time course of body weight changes. (F) The survival rate of different antibody and oseltamivir treatment groups delivered at 24 hours after the H5N6 SC14 infection. (G) The time course of body weight changes. (H) The survival rate of different antibody and oseltamivir treatment groups delivered at 72 hours after the H5N6 SC14 virus infection. Survival rate was calculated as percent survival within each experimental group (n = 6 mice per group).